PlainPharmaWatch

CMS Open Payments · Program Year 2024

Zevra Therapeutics Inc

Zevra Therapeutics Inc reported $1,546,445.40 in payments to 25 physicians and teaching hospitals across 103 transactions.

See the rankings → How this is sourced
$1.5M
Total payments
103
Transactions
25
Recipients
#516
of 1,925 companies

Zevra Therapeutics Inc reported $1,546,445.40 in payments to 25 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #516 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $61.9K per recipient across 4 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Zevra Therapeutics Inc pairs above-median payment volume with a moderately concentrated payment pattern.

#516
of 1,925 companies
0.0%
of all US industry payments
0.3%
paid to its single top recipient
4
payment categories

How Zevra Therapeutics Inc ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Zevra Therapeutics Inc's total vs. every reporting company

CMS Open Payments, Program Year 2024

$1,546,445 Top 27% higher than 73% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). This entry sits in this band. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Zevra Therapeutics Inc

$1,546,445.40: that is what Zevra Therapeutics Inc reported in payments to 25 physicians and teaching hospitals during Program Year 2024, spread across 103 transactions ($15.0K per transaction, $61.9K per recipient). The company sits at rank #516 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 4 general-payment categories charted below, "Consulting Fee" is the largest at $29.8K across 10 transactions, 1.9% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

Across 4 types of general payments, Zevra Therapeutics Inc's largest category was "Consulting Fee" at $29.8K - 1.9% of the company's reported total.

How Zevra Therapeutics Inc divides its payments

How the reported total splits across payment categories

1. Consulting Fee$29.8K2. Honoraria$2.8K3. Travel and Lodging$1.9K4. Food and Beverage$296.54
Payment Type Amount Transactions
Consulting Fee $29.8K 10
Honoraria $2.8K 1
Travel and Lodging $1.9K 2
Food and Beverage $296.54 12

Recipient Concentration in General Payments

The five largest recipient relationships account for $28,698.91 (82.4%) of $34,822.81 in this company's General Payments records across 22 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Zevra Therapeutics Inc

The five named recipients with the highest reported General Payments from this company

Chiadikaobi Uchendu Onyike$11.7KNathan Benjamin Fountain$10.1KKarl S. Roth$4.1KHolly Jean Bernal$1.4KStephanie J Offord$1.4K
  1. 1

    Chiadikaobi Uchendu Onyike

    $11,700.00 across 1 reported transactions

  2. 2

    Nathan Benjamin Fountain

    $10,104.59 across 2 reported transactions

  3. 3

    Karl S. Roth

    $4,094.32 across 3 reported transactions

  4. 4

    Holly Jean Bernal

    $1,400.00 across 1 reported transactions

  5. 5

    Stephanie J Offord

    $1,400.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $15.0K. Average per recipient: $61.9K.

Total Amount

$1,546,445.40

Avg per Transaction

$15.0K

Avg per Recipient

$61.9K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Zevra Therapeutics Inc Share

0.0%

#516 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Zevra Therapeutics Inc

Fresenius USA Marketing, Inc.

$1.6M 10,547 recipients

Instylla, Inc.

$1.5M 124 recipients

Balt USA, LLC

$1.5M 1,737 recipients

Myriad Genetic Laboratories, Inc.

$1.6M 11,970 recipients

Collegium Pharmaceutical, Inc.

$1.5M 36,863 recipients

Invivyd Inc

$1.5M 268 recipients

Frequently Asked Questions

How much did Zevra Therapeutics Inc pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $1,546,445.40 from Zevra Therapeutics Inc to physicians and hospitals across 103 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Zevra Therapeutics Inc? ▾
Averaging $61.9K per recipient, Zevra Therapeutics Inc's 2024 payments reached 25 physicians and teaching hospitals.
What types of payments did Zevra Therapeutics Inc make? ▾
Zevra Therapeutics Inc made 4 different types of general payments (consulting, meals, travel, and similar categories). The largest general-payment category was "Consulting Fee" at $29.8K, representing 1.9% of the company's reported total.
How does Zevra Therapeutics Inc rank among pharmaceutical companies? ▾
Zevra Therapeutics Inc ranks #516 out of 1,925 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from Zevra Therapeutics Inc? ▾
Zevra Therapeutics Inc's 103 transactions to 25 recipients in 2024 averaged $15.0K per transaction.
Where does the payment data for Zevra Therapeutics Inc come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Zevra Therapeutics Inc's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.